{
    "nct_id": "NCT05141643",
    "official_title": "18F-FAC PET Imaging to Quantify Gemcitabine Tumor Drug Uptake and Biodistribution in Pancreatic Cancer Patients",
    "inclusion_criteria": "* Patients with histologically-confirmed (confirmed at MSKCC) PDAC\n* Patients must be ≥ 18 years old\n* Signed, written Institutional Review Board (IRB)-approved Informed Consent Form (ICF).\n* Measurable or evaluable solid disease on computed tomography (CT) or magnetic resonance imaging (MRI) scan per RECIST v1.1.\n* Karnofsky Performance Status ≥70%.\n* Life expectancy ≥3 months.\n* A negative serum pregnancy test, within 1 week of the procedure, if the patient is female of reproductive potential.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who cannot undergo PET/CT scanning (i.e. because of weight limits, claustrophobia).\n* Women who are pregnant or breast-feeding.",
    "miscellaneous_criteria": ""
}